Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
Rhea-AI Summary
Syra Health (NASDAQ: SYRA) has secured two significant contracts: a new healthcare workforce contract with the Washington D.C. government valued at up to $1 million, and a $1.2 million extension to an existing contract with Indiana's NeuroDiagnostic Institute, bringing its total value to $18.7 million.
The D.C. contract, awarded on behalf of the Office of the State Superintendent of Education, involves deploying registered nurses, licensed practical nurses, and certified nursing assistants to provide healthcare services to students. This one-year agreement includes extension options and requires developing individualized service plans for students.
The expanded Indiana contract continues Syra Health's support in providing healthcare professionals to evaluate and treat patients with complex neuropsychiatric illnesses at the NeuroDiagnostic Institute. This marks Syra Health's fourth contract with the D.C. government, building on their partnership with the NeuroDiagnostic Institute that began in 2021.
Positive
- Secured new contract worth up to $1M with Washington D.C. government
- Existing contract with Indiana increased by $1.2M to total $18.7M
- Fourth contract secured with Washington D.C. government, showing strong client relationship
- Contract includes potential extensions, indicating growth opportunities
Negative
- None.
News Market Reaction
On the day this news was published, SYRA gained 50.70%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Syra Health will deploy registered nurses, licensed practical nurses, and certified nursing assistants to deliver healthcare services to students as part of
In addition to this new contract, Syra Health continues to expand its support for the Indiana Family and Social Services Administration's NeuroDiagnostic Institute. Syra Health provides healthcare professionals to the Institute to evaluate and treat patients with complex neuropsychiatric illnesses.
"These contracts highlight our deep commitment to driving better health outcomes," said Dr. Deepika Vuppalanchi, CEO of Syra Health. "By providing tailored services that alleviate staffing shortages and ensure continuity of care, we are not only addressing immediate healthcare needs but also supporting long-term solutions. This marks our fourth contract with the
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world.
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For Investor or Media Inquiries:
Christine Drury
IR/PR
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-wins-new-workforce-contract-announces-existing-contract-extension-302343703.html
SOURCE Syra Health